Are the synergistic effects of high-volume haemofiltration and enhanced adsorption the missing key in sepsis modulation?

Nephrology Dialysis Transplantation

Volumn 24, Issue 2, 2009, Pages 354-357

  Joannes Boyau, Olivier ^a   Honore, Patrick M ^b   Boer, Willem ^c   Collin, Vincent ^d  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b Clinique Saint Pierre of Ottignies   (Belgium)

^c Sittard Geleen Heerlen   (Netherlands)

^d Cliniques de l'Europe   (Belgium)

Author keywords

Acute kidney injury; Adsorption; Haemofiltration; Sepsis; Septic shock

Indexed keywords

CYTOKINE;

ADSORPTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEMODYNAMICS; HEMOFILTRATION; HUMAN; KIDNEY FAILURE; KIDNEY INJURY; NONHUMAN; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPARATION TECHNIQUE; SEPTIC SHOCK; SURVIVAL RATE;

ADSORPTION; ANIMALS; CYTOKINES; HEMODYNAMICS; HEMOFILTRATION; HUMANS; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 58449098784     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn666     Document Type: Note

References (33)

1. Vincent J-L, Atalan HK. Epidemiology of severe sepsis in the intensive care unit. Br J Hosp Med 2008; 69: 442-443
2. Damas P, Canivet JL, de Groote D et al. Sepsis and serum cytokines concentrations. Crit Care Med 1997; 25: 405-412
3. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern 1993; 119: 771-778
4. Rimmelé T, Assadi A, Cattenoz M et al. High-volume haemofiltration with a new haemofiltration membrane getting enhanced adsorption properties in septic pigs. Nephrol Dial Transplant 2008;
5. Ronco C, Tetta C, Mariano F et al. Interpreting the mechanism of continuous renal replacement therapy in sepsis. The peak concentration hypothesis. Artif Organs 2003; 27: 792-801
6. Ronco C, Bellomo R. Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002; 733-747
7. Ronco C, Ricci Z, Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH. EDTRA ERCA J 2002; 2: 13-18
8. Honoré PM, Joannes-Boyau O. High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 2004; 27: 1077-1082
9. Honoré PM, Matson JR. Extracorporeal removal for sepsis: acting at the tissue level - the beginning of a new era for this treatment modality in septic shock. Crit Care Med 2004; 32: 896-897
10. Honoré PM, Jamez J, Wauthier M et al. Prospective evaluation of short-time high volume isovolemic hemofiltration on the haemodynamic course and outcome of patients with refractory septic shock. Crit Care Nephrol 1998; 90: 87-99
11. Honoré PM, Zydney AL, Matson JR. High volume and high permeability haemofiltration in sepsis. The evidences and the key issues. Care Crit Ill 2003; 3: 69-76
12. Klouche K, Cavadore P, Portales P et al. Continuous veno-venous hemofiltration improves hemodynamic in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Nephrol 2002; 15: 150-157
13. Di Carlo JV, Alexander SR. Hemofiltration for cytokine-driven illness: the mediator delivery hypothesis. Review. Int J Artific Organs 2005; 28: 777-786
14. Olszewski WL. The lymphatic system in body homeostasis: physiological conditions. Lymph Fat Res Biol 2003; 1: 11-21
15. Onarherim H, Missavage E, Gunther RA et al. Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J Surg Res 1991; 50: 259-265
16. Wasserman K, Mayerson HS. Dynamics of lymph and plasma protein and exchange. Cardiologia 1952; 21: 296-307
17. Honore PM, Joannes-Boyau O, Collin V et al. Practical daily management of extra-renal continuous removal. Reanimation 2008; 17: 472-478
18. Honoré PM, Matson JR. Hemoflitration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care 2002; 6: 394-396
19. Sykora R, Chvojka J, Krouzecky A et al. High versus standard-volume haemofiltration in hyperdynamic porcine peritonitis: effects beyond haemodynamics? Intensive Care Med 2008; 34. [Epub ahead of print]
20. Honore PM, Joannes-Boyau O, Gressens B. Blood and plasma treatments: high-volume hemofiltration - a global view. Contrib Nephrol 2007; 156: 371-386
21. Yekebas EF, Eisenberger CF, Ohnnesorge H et al. Attenuation of sepsis-immunoparalysis with continuous venovenous haemofiltration in experimental porcine pancreatitis. Crit Care Med 2001; 29: 1423-1430
22. Bone RC, Sir Isaac Newton. Sepsis, SIRS and CARS. Crit Care Med 1996; 24: 1125-1128
23. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004; 32: 801-805
24. Li CM, Chen JH, Zhang P et al. Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth Intensive Care 2007; 35: 911-919
25. Matson JR, Zydney AR, Honore PM. Blood filtration: new opportunities and the implications on system biology. Crit Care Resuc 2004; 6: 209-218
26. Palevsky PM, Zhang JH, O'Connor TZ et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20
27. Ronco C, Honore PM. Renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 1959-1962 (Letter)
28. Ronco C, Cruz D, Oudemans-van-Straaten HM et al. Dialysis dose in acute kidney injury: no time for therapeutic nihilism - a critical appraisal of the Acute Renal Failure Trial Network study. Crit Care 2008; 12: 308
29. ANZICS Clinical Trials Group. Augmented vs. normal renal replacement therapy in severe acute renal failure (ARF-Renal Study). http://clinicaltrials. gov/ct2/show/NCT00221013 (September 2008, last accessed)
30. Joannes-Boyau O, Honore PM. Hemofiltration Study: IVOIRE Study. http://clinicaltrials.gov/ct2/show/NCT00241228 (September 2008, last accessed)
31. Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration. Lancet 2000; 356: 26-30
32. Bellomo R, Kellum JA, Mehta R et al. The acute dialysis quality initiative II: the Vicenza conference. Adv Ren Replace Ther 2002; 9: 290-293
33. Schiffl H, Lang SM, Fisher R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 305-310